Crossmark

Mucosal glycans: key drivers of the development of inflammatory bowel disease and a potential new therapeutic target

Crossref DOI link: https://doi.org/10.1038/s41575-025-01164-7

Published Online: 2026-01-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pinho, Salomé S. https://orcid.org/0000-0002-3484-5162
Torres, Joana https://orcid.org/0000-0003-2895-5821
Colombel, Jean-Frederic https://orcid.org/0000-0001-6472-249X
License Information

Text and Data Mining valid from 2026-01-02

Version of Record valid from 2026-01-02
More Information

Article History

Accepted: 26 November 2025

First Online: 2 January 2026

Competing interests

: The authors declare no competing interests.